Tamoxifen may increase risk of uterine sarcomaBMJ 2002; 325 doi: https://doi.org/10.1136/bmj.325.7354.7/a (Published 06 July 2002) Cite this as: BMJ 2002;325:7
- Scott Gottlieb
- New York
The US Food and Drug Administration issued a new warning on the drug tamoxifen, advising doctors that it may cause an aggressive cancer of the uterus.
The labelling of tamoxifen will be changed to add a “black box” warning about the newly identified risk of uterine sarcoma, the drug agency said. Black boxes are used to draw attention to problems that are serious and potentially life …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial